# Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial

> **NCT04413214** · PHASE1 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 9 (actual)

## Conditions studied

- Oral Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Carrimycin

## Key facts

- **NCT ID:** NCT04413214
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-20
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04413214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04413214, "Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04413214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*